A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 update

Brachytherapy
Mark K BuyyounouskiEric M Horwitz

Abstract

To help establish patterns of care and standards of care of interstitial permanent low-dose-rate (LDR) and temporary high-dose-rate brachytherapy for prostate cancer and to compare the results with a similar 1998 American Brachytherapy Society (ABS) survey. A comprehensive questionnaire intended to survey specific details of current clinical brachytherapy practice was provided to the participants of the seventh ABS Prostate Brachytherapy School. Responses were tabulated and descriptive statistics are reported. Sixty-five brachytherapy practitioners responded to the survey. Eighty-nine percent (89%) of respondents performed LDR and 49% perform high-dose-rate brachytherapy. The median number of years of experience for LDR brachytherapists increased from 5 to 10 years over the course of the 12 years since the preceding survey. Compared with the first ABS, a smaller proportion of respondents received formal brachytherapy residency training (43% vs. 56%) or formal "hands-on" brachytherapy training (15% vs. 63%). There has been a marked decline in the utilization of the Mick applicator (Mick Radio-Nuclear Instruments, Inc., Mount Vernon, NY, USA) (60% vs. 28%) and an increase in the use of stranded seeds (40% vs. 11%). Compliance wit...Continue Reading

References

Feb 11, 1998·International Journal of Radiation Oncology, Biology, Physics·B R PrestidgeW S Bice
Jul 1, 1999·International Journal of Radiation Oncology, Biology, Physics·S NagR Nath
Jul 2, 2005·International Journal of Radiation Oncology, Biology, Physics·Steven J FeigenbergHoward Sandler
Apr 19, 2011·Brachytherapy·UNKNOWN Expert Panel on Radiation Oncology-ProstateGregory Merrick

❮ Previous
Next ❯

Citations

Feb 18, 2014·International Journal of Computer Assisted Radiology and Surgery·Hossein SadjadiGabor Fichtinger
Jan 23, 2016·Brachytherapy·Yvonne D PhamRahul D Tendulkar
Feb 18, 2014·Journal of Medical Imaging and Radiation Oncology·Jane van NieuwenhuysenNikki Caswell
Feb 18, 2014·Journal of Medical Imaging and Radiation Oncology·Nadine BeydounDavid Malouf
Sep 21, 2013·Brachytherapy·Usama MahmoodAndrew Lee
Jan 4, 2015·Australasian Physical & Engineering Sciences in Medicine·Kent J GregoryGiovanni Bibbo
Mar 3, 2015·Clinical Oncology : a Journal of the Royal College of Radiologists·A J StewartI Locke
Aug 26, 2014·International Journal of Radiation Oncology, Biology, Physics·Nikhil G ThakerSteven J Frank
Sep 14, 2016·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Rhian Siân DaviesJason Francis Lester
Dec 15, 2016·Brachytherapy·Brian J DavisNeha Vapiwala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.